NYMOX PHARMACEUTICAL CORPORATION General And Administrative Expense
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported General And Administrative Expense of $142.00 thousand for the 3-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GeneralAndAdministrativeExpense · last filed 2025-01-02
- NYMOX PHARMACEUTICAL CORPORATION general and administrative expense for the quarter ending 2024-09-30 was $142.00K, a 59.77% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION general and administrative expense for the quarter ending 2023-09-30 was $353.00K, a 39.76% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION general and administrative expense for the quarter ending 2023-06-30 was $505.00K, a 47.56% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION general and administrative expense for the quarter ending 2023-03-31 was $665.00K, a 10.14% decline year-over-year.
| Period end | General And Administrative Expense 3 month | General And Administrative Expense 6 month | General And Administrative Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $142.00K 6-K · filed 2025-01-02 | $839.00K 6-K · filed 2025-01-02 | |
| 2023-09-30 | $353.00K 6-K · filed 2025-01-02 | $858.00K derived: sum of 2 quarters · filed 2025-01-02 | $1.52M 6-K · filed 2025-01-02 |
| 2023-06-30 | $505.00K 6-K · filed 2023-08-14 | $1.17M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $665.00K 6-K · filed 2023-05-12 | ||
| 2022-09-30 | $586.00K 6-K · filed 2023-11-15 | $1.55M derived: sum of 2 quarters · filed 2023-11-15 | $2.29M 6-K · filed 2023-11-15 |
| 2022-06-30 | $963.00K 6-K · filed 2023-08-14 | $1.70M 6-K · filed 2023-08-14 | |
| 2022-03-31 | $740.00K 6-K · filed 2023-05-12 | ||
| 2021-09-30 | $1.46M 6-K/A · filed 2022-11-16 | $3.37M derived: sum of 2 quarters · filed 2022-11-16 | $4.37M 6-K/A · filed 2022-11-16 |
| 2021-06-30 | $1.91M 6-K · filed 2022-08-15 | $2.92M 6-K · filed 2022-08-15 | |
| 2021-03-31 | $1.00M 6-K · filed 2022-05-13 |